Clinical Grade Non-Transfusable Mobilized Peripheral Blood Mononuclear Cells, G-CSF + Plerixafor, Frozen
Mobilized Human Peripheral Blood Mononuclear Cells (MNCs) are isolated from donors injected with either 10μg/kg/day of G-CSF over 3 to 5 days and 240μg/kg of Plerixafor (aka Mozobil®) the day before collection. Isolated MNCs are characterized by flow cytometry to ensure a highly enriched and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols. All reagents and devices used in the collection and separation process are certified clinical grade. This item is for research use only.
|Cell and Tissue Source||Peripheral Blood|
|Product Type||Primary Cells|
|Cell Type||Mononuclear Cells|
|Donor Attributes||HIV-, HepB-, HepC-|
|Viability||≥80% by Flow Cytometry|
|Contains||CryoStor™ CS10 (10% DMSO)|
|Injections||10μg/kg/day of G-CSF & 240μg/kg Plerixafor the day before collection|